Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes

Nina Wettschureck, Hartmut Rütten, Alexandra Zywietz, Doris Gehring, Tom M. Wilkie, Ju Chen, Kenneth R. Chien, Stefan Offermanns

Research output: Contribution to journalArticle

286 Citations (Scopus)

Abstract

Myocardial hypertrophy is an adaptational response of the heart to increased work load, but it is also associated with a high risk of cardiac mortality1-3 due to its established role in the development of cardiac failure, one of the leading causes of death in developed countries. Multiple growth factors2,3 and various downstream signaling pathways involving, for example, ras4, gp-130 (ref. 4), JNK/p38 (refs. 5,6) and calcineurin/NFAT/CaMkinase7 have been implicated in the hypertrophic response. However, there is evidence that the initial phase in the development of myocardial hypertrophy involves the formation of cardiac para- and/or autocrine factors like endothelin-1, norepinephrine or angiotensin II 11 (refs. 7,8), the receptors of which are coupled to G-proteins of the Gq/11- G12/13- and GI/o-families5,6,8. Cardiomyocyte-specific transgenic overexpression of α1-adrenergic or angiotensin (AT1)-receptors as well as of the Gq αa-subunit, Gαq, results in myocardial hypertrophy9-12. These data demonstrate that chronic activation of the Gq/G11-family is sufficient to induce myocardial hypertrophy. In order to test whether Gq/G11, mediate the physiological hypertrophy response to pressure overload, we generated a mouse line lacking both Gαq and Gα11 in cardiomyocytes. These mice showed no detectable ventricular hypertrophy in response to pressure-over-load induced by aortic constriction. The complete lack of a hypertrophic response proves that the Gq/G11-mediated pathway is essential for cardiac hypertrophy induced by pressure overload and makes this signaling process an interesting target for interventions to prevent myocardial hypertrophy.

Original languageEnglish (US)
Pages (from-to)1236-1240
Number of pages5
JournalNature Medicine
Volume7
Issue number11
DOIs
StatePublished - 2001

Fingerprint

Cardiac Myocytes
Hypertrophy
Pressure
Gq-G11 GTP-Binding Protein alpha Subunits
Angiotensin Type 1 Receptor
Calcineurin
Endothelin-1
Angiotensin II
Adrenergic Agents
Norepinephrine
Chemical activation
Cardiomegaly
Workload
Developed Countries
Constriction
Cause of Death
Heart Failure
Growth

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. / Wettschureck, Nina; Rütten, Hartmut; Zywietz, Alexandra; Gehring, Doris; Wilkie, Tom M.; Chen, Ju; Chien, Kenneth R.; Offermanns, Stefan.

In: Nature Medicine, Vol. 7, No. 11, 2001, p. 1236-1240.

Research output: Contribution to journalArticle

Wettschureck, N, Rütten, H, Zywietz, A, Gehring, D, Wilkie, TM, Chen, J, Chien, KR & Offermanns, S 2001, 'Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes', Nature Medicine, vol. 7, no. 11, pp. 1236-1240. https://doi.org/10.1038/nm1101-1236
Wettschureck, Nina ; Rütten, Hartmut ; Zywietz, Alexandra ; Gehring, Doris ; Wilkie, Tom M. ; Chen, Ju ; Chien, Kenneth R. ; Offermanns, Stefan. / Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. In: Nature Medicine. 2001 ; Vol. 7, No. 11. pp. 1236-1240.
@article{e1ab6b637f964c48892a6417ab0307f3,
title = "Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes",
abstract = "Myocardial hypertrophy is an adaptational response of the heart to increased work load, but it is also associated with a high risk of cardiac mortality1-3 due to its established role in the development of cardiac failure, one of the leading causes of death in developed countries. Multiple growth factors2,3 and various downstream signaling pathways involving, for example, ras4, gp-130 (ref. 4), JNK/p38 (refs. 5,6) and calcineurin/NFAT/CaMkinase7 have been implicated in the hypertrophic response. However, there is evidence that the initial phase in the development of myocardial hypertrophy involves the formation of cardiac para- and/or autocrine factors like endothelin-1, norepinephrine or angiotensin II 11 (refs. 7,8), the receptors of which are coupled to G-proteins of the Gq/11- G12/13- and GI/o-families5,6,8. Cardiomyocyte-specific transgenic overexpression of α1-adrenergic or angiotensin (AT1)-receptors as well as of the Gq αa-subunit, Gαq, results in myocardial hypertrophy9-12. These data demonstrate that chronic activation of the Gq/G11-family is sufficient to induce myocardial hypertrophy. In order to test whether Gq/G11, mediate the physiological hypertrophy response to pressure overload, we generated a mouse line lacking both Gαq and Gα11 in cardiomyocytes. These mice showed no detectable ventricular hypertrophy in response to pressure-over-load induced by aortic constriction. The complete lack of a hypertrophic response proves that the Gq/G11-mediated pathway is essential for cardiac hypertrophy induced by pressure overload and makes this signaling process an interesting target for interventions to prevent myocardial hypertrophy.",
author = "Nina Wettschureck and Hartmut R{\"u}tten and Alexandra Zywietz and Doris Gehring and Wilkie, {Tom M.} and Ju Chen and Chien, {Kenneth R.} and Stefan Offermanns",
year = "2001",
doi = "10.1038/nm1101-1236",
language = "English (US)",
volume = "7",
pages = "1236--1240",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes

AU - Wettschureck, Nina

AU - Rütten, Hartmut

AU - Zywietz, Alexandra

AU - Gehring, Doris

AU - Wilkie, Tom M.

AU - Chen, Ju

AU - Chien, Kenneth R.

AU - Offermanns, Stefan

PY - 2001

Y1 - 2001

N2 - Myocardial hypertrophy is an adaptational response of the heart to increased work load, but it is also associated with a high risk of cardiac mortality1-3 due to its established role in the development of cardiac failure, one of the leading causes of death in developed countries. Multiple growth factors2,3 and various downstream signaling pathways involving, for example, ras4, gp-130 (ref. 4), JNK/p38 (refs. 5,6) and calcineurin/NFAT/CaMkinase7 have been implicated in the hypertrophic response. However, there is evidence that the initial phase in the development of myocardial hypertrophy involves the formation of cardiac para- and/or autocrine factors like endothelin-1, norepinephrine or angiotensin II 11 (refs. 7,8), the receptors of which are coupled to G-proteins of the Gq/11- G12/13- and GI/o-families5,6,8. Cardiomyocyte-specific transgenic overexpression of α1-adrenergic or angiotensin (AT1)-receptors as well as of the Gq αa-subunit, Gαq, results in myocardial hypertrophy9-12. These data demonstrate that chronic activation of the Gq/G11-family is sufficient to induce myocardial hypertrophy. In order to test whether Gq/G11, mediate the physiological hypertrophy response to pressure overload, we generated a mouse line lacking both Gαq and Gα11 in cardiomyocytes. These mice showed no detectable ventricular hypertrophy in response to pressure-over-load induced by aortic constriction. The complete lack of a hypertrophic response proves that the Gq/G11-mediated pathway is essential for cardiac hypertrophy induced by pressure overload and makes this signaling process an interesting target for interventions to prevent myocardial hypertrophy.

AB - Myocardial hypertrophy is an adaptational response of the heart to increased work load, but it is also associated with a high risk of cardiac mortality1-3 due to its established role in the development of cardiac failure, one of the leading causes of death in developed countries. Multiple growth factors2,3 and various downstream signaling pathways involving, for example, ras4, gp-130 (ref. 4), JNK/p38 (refs. 5,6) and calcineurin/NFAT/CaMkinase7 have been implicated in the hypertrophic response. However, there is evidence that the initial phase in the development of myocardial hypertrophy involves the formation of cardiac para- and/or autocrine factors like endothelin-1, norepinephrine or angiotensin II 11 (refs. 7,8), the receptors of which are coupled to G-proteins of the Gq/11- G12/13- and GI/o-families5,6,8. Cardiomyocyte-specific transgenic overexpression of α1-adrenergic or angiotensin (AT1)-receptors as well as of the Gq αa-subunit, Gαq, results in myocardial hypertrophy9-12. These data demonstrate that chronic activation of the Gq/G11-family is sufficient to induce myocardial hypertrophy. In order to test whether Gq/G11, mediate the physiological hypertrophy response to pressure overload, we generated a mouse line lacking both Gαq and Gα11 in cardiomyocytes. These mice showed no detectable ventricular hypertrophy in response to pressure-over-load induced by aortic constriction. The complete lack of a hypertrophic response proves that the Gq/G11-mediated pathway is essential for cardiac hypertrophy induced by pressure overload and makes this signaling process an interesting target for interventions to prevent myocardial hypertrophy.

UR - http://www.scopus.com/inward/record.url?scp=0035166852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035166852&partnerID=8YFLogxK

U2 - 10.1038/nm1101-1236

DO - 10.1038/nm1101-1236

M3 - Article

C2 - 11689889

AN - SCOPUS:0035166852

VL - 7

SP - 1236

EP - 1240

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 11

ER -